Xlife Sciences AG (XSWX:XLS) Cash per Share: CHF0.18 (As of Dec. 2025)

What is Xlife Sciences AG Cash per Share?

Xlife Sciences AG XSWX:XLS 53 Cash per Share is CHF0.18 as of Dec. 2025. GuruFocus rates XSWX:XLS with a GF Score™ of 53/100 and a GF Value™ of CHF7.25 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Xlife Sciences AG's Cash per Share for the quarter that ended in Dec. 2025 was CHF0.18.

Xlife Sciences AG (XSWX:XLS) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Xlife Sciences AG Cash per Share Related Terms

Xlife Sciences AG Cash per Share Historical Data

* Premium members only.

The historical data trend for Xlife Sciences AG's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xlife Sciences AG Cash per Share Chart

Xlife Sciences AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

0.39

0.04

0.02

0.18

Xlife Sciences AG Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Cash per Share	Get a 7-Day Free Trial										0.04	0.02	0.02	0.01	0.18

53GF Score

Xlife Sciences AG XSWX:XLS

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Xlife Sciences AG Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Xlife Sciences AG's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	1.051	/	5.77
	=	0.18

Xlife Sciences AG's Cash per Share for the quarter that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	1.051	/	5.77
	=	0.18

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of CHF0.18 mean?

Xlife Sciences AG (XSWX:XLS) has a Cash per Share of CHF0.18 as of Dec. 2025. Cash per share is the per-share value of a company's available cash. View historical data for Xlife Sciences AG and its competitors.

Is Xlife Sciences AG's Cash per Share too high?

Xlife Sciences AG's current Cash per Share is CHF0.18. Overall, Xlife Sciences AG has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Xlife Sciences AG's Cash per Share compare to VRTX and REGN?

Xlife Sciences AG's Cash per Share of CHF0.18 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Biotechnology company?

A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Xlife Sciences AG and its competitors. Xlife Sciences AG's current Cash per Share is CHF0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Xlife Sciences AG stock overvalued right now?

Based on GuruFocus' analysis, Xlife Sciences AG (XSWX:XLS) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF7.25, compared to a current price of CHF18.15 — trading 150.3% above its estimated fair value. The current Cash per Share is CHF0.18. Xlife Sciences AG's overall GF Score™ is 53/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Xlife Sciences AG (XSWX:XLS), the current Cash per Share is CHF0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xlife Sciences AG (XSWX:XLS) Overvalued in 2026?

Based on GuruFocus' analysis, Xlife Sciences AG stock appears to be overvalued. The current stock price of CHF18.15 is trading 150.3% above its estimated GF Value™ of CHF7.25. GuruFocus considers Xlife Sciences AG to be Significantly Overvalued.

Key valuation signals for XSWX:XLS:

Cash per Share: CHF0.18
GF Value™: CHF7.25 vs. price of CHF18.15 (150.3% above fair value)
GF Score™: 53/100 with 10 warning signs

No single metric tells the full story. See the XSWX:XLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xlife Sciences AG Business Description

Industry Healthcare Biotechnology

Comparable Companies XSWX:MOLN XSWX:BIOV XSWX:MMTX XSWX:ADXN XSWX:SANN XSWX:NWRN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX

Other Exchanges XLSz:UK XLS:Germany

Address Talacker 35, Zurich, CHE, 8001

Website https://www.xlifesciences.ch

Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high-unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments, which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial Intelligence/Digital Medicine.

53GF Score

Get the complete analysis for XSWX:XLS

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF18.15

Price

CHF7.25

GF Value

View XSWX:XLS Analysis

See Cash per Share data for all stocks →